1. Leukemia. 2015 Dec;29(12):2438-41. doi: 10.1038/leu.2015.121. Epub 2015 May
15.

Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of 
the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

Tokumasu M(1), Murata C(2), Shimada A(3), Ohki K(2), Hayashi Y(2), Saito AM(4), 
Fujimoto J(5), Horibe K(4), Nagao M(6), Itoh H(6), Kamikubo Y(6), Nakayama H(7), 
Kinoshita A(8), Tomizawa D(9), Taga T(10), Tawa A(11), Tanaka S(12), Heike T(1), 
Adachi S(6).

Author information:
(1)Department of Pediatrics, Kyoto University, Kyoto, Japan.
(2)Department of Hematology/Oncology, Gunma Children's Medical Center, 
Shibukawa, Japan.
(3)Department of Pediatrics, Okayama University, Okayama, Japan.
(4)Clinical Research Center, National Hospital Organization, Nagoya Medical 
Center, Nagoya, Japan.
(5)Clinical Research Center, National Center for Child Health and Development, 
Tokyo, Japan.
(6)Human Health Sciences, Kyoto University, Kyoto, Japan.
(7)Department of Pediatrics, Fukuoka-Higashi Medical Center, National Hospital 
Organization, Koga, Japan.
(8)Department of Pediatrics, St Marianna University School of Medicine, 
Kawasaki, Japan.
(9)Division of Leukemia and Lymphoma, Children's Cancer Center, National Center 
for Child Health and Development, Tokyo, Japan.
(10)Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan.
(11)Department of Pediatrics, National Hospital Organization, Osaka Medical 
Center, Osaka, Japan.
(12)Department of Pharmacoepidemiology, Kyoto University, Kyoto, Japan.

DOI: 10.1038/leu.2015.121
PMID: 25975190 [Indexed for MEDLINE]